Matthew Baker Turner - 13 Nov 2025 Form 4 Insider Report for Paysign, Inc. (PAYS)

Reporting relationship: PRES., PATIENT AFFORDABILITY
Issuer ticker: PAYS
Reported as of: 13 Nov 2025
Net transaction value: -$62,637
SEC form: 4
Accepted by SEC: 04 Sep 2026, 18:42:33 UTC
Prior SEC filing: 04 Sep 2026
Source filing: View source filing
Reporting owner signature: /s/ Matthew Baker Turner

Key filing fact

Matthew Baker Turner filed Form 4 for Paysign, Inc. (PAYS) on 04 Sep 2026.

Key facts

This page summarizes Matthew Baker Turner's Form 4 filing for Paysign, Inc. (PAYS).
3 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 04 Sep 2026, 18:42.

Change

Previous filing in this sequence was filed on 04 Sep 2026.
Current net transaction value: -$62,637.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002136145 Primary reporting owner

Turner Matthew Baker

Relationship: PRES., PATIENT AFFORDABILITY
Address: 2615 ST ROSE PARKWAY, HENDERSON
Signature: /s/ Matthew Baker Turner
Signature date: 04 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PAYS transaction

Common Stock

Award

Transaction value
Shares: +233,333
Change %: +99%
Price: $0.000000^*
Shares after: 470,000
Date: 13 Nov 2025
Ownership: Direct
Footnotes: F1

PAYS transaction

Common Stock

Sale

Transaction value: $62,637
Shares: -15,057
Change %: -3.2%
Price: $4.16
Shares after: 454,943
Date: 03 Feb 2026
Ownership: Direct
Footnotes: F2

PAYS transaction

Common Stock

Tax liability

Transaction value
Shares: -50,681
Change %: -11%
Price: $6.72^*
Shares after: 404,262
Date: 22 May 2026
Ownership: Direct
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents performance-based restricted stock granted on May 7, 2025, with the performance goal deemed satisfied on November 13, 2025 based upon the achievement of a specified earnings target. The restricted stock will vest and be delivered as to 1/3 of the shares on each of May 22, 2026, May 26, 2027, and May 24, 2028, subject to the reporting person's continued service to the issuer through and on the applicable vesting date.

Footnote F2

Represents shares of common stock sold to satisfy certain tax withholding obligations associated with the vesting of restricted stock.

Footnote F3

Represents shares of common stock withheld by the issuer to satisfy certain tax withholding obligations associated with the vesting of restricted stock and performance-based restricted stock.